Transplantation and Cellular Therapy

Published by: Elsevier Inc.  

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Dahi
    Dahi
  4. Papadopoulos
    Papadopoulos
  5. Scaradavou
    Scaradavou
  6. Park
    Park
  7. Palomba
    Palomba
  8. Politikos
    Politikos
  9. Scordo
    Scordo
  10. Shah
    Shah

Groups

  1. Graduate Medical Education (30)
  2. Department of Medicine (22)
  3. GME, Medicine (22)
  4. Hematologic Malignancies, Division of (21)
  5. Center for Hematologic Malignancies (20)
  6. Bone Marrow Transplant (16)
  7. CTCR Scholars (14)
  8. Survivorship Research (13)
  9. Pediatrics, Department of (12)
  10. MSK Grad Students (10)
Search Within
  1. "Graduate Medical Education"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (8)
  3. Review (3)
  4. Editorial (2)
  5. Guidelines (1)
Groups
  1. Graduate Medical Education (30)
  2. Department of Medicine (22)
  3. GME, Medicine (22)
  4. Hematologic Malignancies, Division of (21)
  5. Center for Hematologic Malignancies (20)
  6. Bone Marrow Transplant (16)

More Groups

People
  1. Miguel-Angel Perales (12)
  2. Sergio Giralt (12)
  3. Warren Fingrut (12)
  4. Parastoo Dahi (8)
  5. Andromachi Scaradavou (7)
  6. Esperanza Papadopoulos (7)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (2)
  4. 2022 (20)
  5. 2021 (1)
Publishers
  1. Elsevier Inc. (30)

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CAR and ALL hematotox scores predict toxicity and outcomes among recipients of brexucabtagene autoleucel for R/R ALL in the real world outcomes collaborative of CAR-T in adult ALL (ROCCA) consortium
    Meeting Abstract

    Valtis, Y.; Lin, C. Y.; Nemirovsky, D.; Devlin, S.; Rejeski, K.; Shah, N. N.; Nair, M. S.; Jeyakumar, N.; Miller, K.; Zhang, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • The clinical TIL experience in melanoma: Past, present, future
    Review

    Smithy, J. W.; Schoenfeld, A. J.; Betof Warner, A.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Cautionary tale of unopposed prophylactic il6 receptor blockade in axicabtagene ciloleucel for large B-cell lymphoma
    Editorial

    Valtis, Y. K.; Park, J. H.
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Late-onset noninfectious pulmonary complications after hematopoietic stem cell transplantation
    Review

    Harris, A. C.; Ganjaei, K.; Vilela, C.; Geyer, A.
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Genetic findings of potential donor origin following hematopoietic cell transplantation: Recommendations on donor disclosure and genetic testing from the World Marrow Donor Association
    Guidelines

    Pryce, A.; Van Eerden, E.; Cody, M.; Oakes, J.; DeSalvo, A.; Bannon, S.; Burlton, C.; Pawson, R.; Fingrut, W.; Barriga, F.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • An optimized search prognosis tool to predict 8/8 HLA allele-matched unrelated donor procurement
    Journal Article

    Davis, E.; Archer, A.; Flynn, J.; Nhaissi, M.; Rapoport, C.; Suri, B.; Wells, D.; Papadopoulos, E.; Politikos, I.; Fingrut, W. B.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Vitamin D insufficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Journal Article

    Nath, K.; Tomas, A. A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. L.; Dahi, P. B.; Fingrut, W. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save

    • Transplantation and Cellular Therapy – authorized name for:

    Name ISSN / ISBN Publisher
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 Unknown
    Transplantation and Cellular Therapy 26666375 Unknown
    Transplantation and Cellular Therapy 2666-6375 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2020
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666375 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2021
    Transplantation and Cellular Therapy 26666375 2024
    Transplantation and Cellular Therapy 26666375 Elsevier B.V.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2023
    Transplantation and Cellular Therapy 26666375 The Authors
    Transplantation and Cellular Therapy 26666367 2022
    Transplantation and Cellular Therapy 26666367 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2024
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Unknown (26666375) 26666375 Elsevier B.V.